KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,971,000 | +166.8% | 89,000 | +138.9% | 1.51% | +90.7% |
| Q2 2016 | $1,863,000 | +8.9% | 37,250 | 0.0% | 0.79% | +1.8% |
| Q1 2016 | $1,710,000 | -33.0% | 37,250 | -10.1% | 0.78% | -27.8% |
| Q4 2015 | $2,554,000 | -5.9% | 41,450 | -15.0% | 1.08% | -30.4% |
| Q3 2015 | $2,714,000 | +3.6% | 48,750 | +35.4% | 1.55% | +15.5% |
| Q2 2015 | $2,620,000 | +64.3% | 36,000 | +30.2% | 1.34% | +62.9% |
| Q1 2015 | $1,595,000 | -37.5% | 27,650 | -37.5% | 0.82% | -12.4% |
| Q4 2014 | $2,552,000 | – | 44,250 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |